Fisher Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fisher Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,435	Closed	-$202K	–	977
2020 Q4	$202K	Buy	+1,435	New	+$184K	﹤0.01%	877
2020 Q3	–	Sell	-2,573	Closed	-$288K	–	895
2020 Q2	$288K	Buy	+2,573	New	+$253K	﹤0.01%	730

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management's XBI Position: Q1 2021 in Review

Fisher Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2021, closing a stake of 1,435 shares — an estimated $202K sold.

Fisher Asset Management first reported a position in XBI in Q2 2020 and held it in 2 quarters. The position peaked at $288K in Q2 2020. 643 funds tracked by Wall St. Rank hold XBI as of Q1 2021.

Fisher Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2021 after selling out during the quarter.
Fisher Asset Management sold 1,435 State Street SPDR S&P Biotech ETF shares in Q1 2021, an estimated $202K.
Fisher Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 2 quarters.
Fisher Asset Management's State Street SPDR S&P Biotech ETF position peaked at $288K in Q2 2020.
643 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2021.

Based on Fisher Asset Management's 13F filing for Q1 2021, filed 27 Apr 2021.